Tinti, M.D.; De Gennaro, L.; Limonta, R.; De Maria, R.; Carigi, S.; Bianco, M.; Di Nora, C.; Manca, P.; Matassini, M.V.; Rizzello, V.;
et al. Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF. J. Clin. Med. 2025, 14, 8730.
https://doi.org/10.3390/jcm14248730
AMA Style
Tinti MD, De Gennaro L, Limonta R, De Maria R, Carigi S, Bianco M, Di Nora C, Manca P, Matassini MV, Rizzello V,
et al. Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF. Journal of Clinical Medicine. 2025; 14(24):8730.
https://doi.org/10.3390/jcm14248730
Chicago/Turabian Style
Tinti, Maria Denitza, Luisa De Gennaro, Raul Limonta, Renata De Maria, Samuela Carigi, Matteo Bianco, Concetta Di Nora, Paolo Manca, Maria Vittoria Matassini, Vittoria Rizzello,
and et al. 2025. "Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF" Journal of Clinical Medicine 14, no. 24: 8730.
https://doi.org/10.3390/jcm14248730
APA Style
Tinti, M. D., De Gennaro, L., Limonta, R., De Maria, R., Carigi, S., Bianco, M., Di Nora, C., Manca, P., Matassini, M. V., Rizzello, V., D’Elia, E., Benvenuto, M., Cittar, M., Halasz, G., Iacoviello, M., Gabrielli, D., Colivicchi, F., Bilato, C., Nardi, F.,
... Oliva, F.
(2025). Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF. Journal of Clinical Medicine, 14(24), 8730.
https://doi.org/10.3390/jcm14248730
